Abstract
Gliomas are the most common form of primary intracranial malignancy. High-grade gliomas, also called glioblastoma multiforme, are the most frequently encountered, carrying the worst prognosis (12 months life expectancy after diagnosis). Therapy of brain tumor has been limited by the lack of effective methods for drug delivery, therefore, it is mandatory to seek for new approches in glioma…